# IPACK Study in Total Knee Arthroplasty Patients

> **NCT03954379** · PHASE4 · COMPLETED · sponsor: **University Health Network, Toronto** · enrollment: 78 (actual)

## Conditions studied

- Knee Replacement Arthroplasty

## Interventions

- **DRUG:** Standard of Care (ACB, SA, peri-op pain management)
- **DRUG:** IPACK and multi-modal analgesic regimen
- **PROCEDURE:** Periarticular Local Anesthetic Infiltration
- **DRUG:** IV Dexamethasone 8mg at the end of surgery as standard of care

## Key facts

- **NCT ID:** NCT03954379
- **Lead sponsor:** University Health Network, Toronto
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-10-24
- **Primary completion:** 2020-12-02
- **Final completion:** 2021-03-31
- **Target enrollment:** 78 (ACTUAL)
- **Last updated:** 2022-04-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03954379

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03954379, "IPACK Study in Total Knee Arthroplasty Patients". Retrieved via AI Analytics 2026-07-25 from https://api.ai-analytics.org/clinical/NCT03954379. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*